Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand better the mechanisms of action of calcitonin gene
related peptide (CGRP) targeted monoclonal antibodies in migraine prevention. Specifically,
the protocol will allow the investigators to determine whether the main site of action of
this novel and recently-approved class of migraine prophylactic drugs act inside or outside
the brain and if so, where.